Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) has provided an announcement.
Shanghai Junshi Biosciences Co., Ltd. has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes a mix of executive, non-executive, and independent non-executive directors, with five committees established to oversee various aspects of the company’s governance. This announcement reflects the company’s commitment to structured governance and strategic oversight, which is crucial for maintaining its position in the competitive biosciences industry.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a joint stock company based in China, operating in the biosciences industry. The company focuses on the development and production of innovative therapeutic products, with a market emphasis on pharmaceuticals and biotechnology solutions.
YTD Price Performance: 20.55%
Average Trading Volume: 1,550,382
Technical Sentiment Signal: Hold
Current Market Cap: HK$26.82B
Learn more about 1877 stock on TipRanks’ Stock Analysis page.